Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

12
Number of overlapping holdings
32.4%
% of IHE's 38 holdings also in PPH
50.0%
% of PPH's 27 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IHE |
Weight in PPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 22.7% | 11.9% | 11.9% | |
JOHNSON & JOHNSON | 22.8% | 6.6% | 6.6% | |
ZOETIS INC | 4.6% | 4.6% | 4.6% | |
BRISTOL-MYERS SQUIBB CO | 4.6% | 4.5% | 4.5% | |
PFIZER INC | 4.5% | 4.4% | 4.4% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to PPH
JOHNSON & JOHNSON | 16.2% | |
ELI LILLY & CO | 10.9% | |
INTRA-CELLULAR THERAPIES INC | 4.6% | |
ROYALTY PHARMA PLC CLASS A | 4.3% | |
CORCEPT THERAPEUTICS INC | 2.1% | |
VIATRIS, INC. | 2.0% | |
PRESTIGE BRANDS HOLDINGS INC | 1.8% | |
JAZZ PHARMACEUTICALS PLC | 1.2% | |
ELANCO ANIMAL HEALTH, INC. | 1.1% | |
AXSOME THERAPEUTICS, INC. | 0.9% |
IHE Underweight Relative to PPH
ABBVIE INC | -6.5% | |
NOVARTIS AG-ADR | -5.2% | |
ASTRAZENECA PLC-SPONS ADR | -4.9% | |
CENCORA INC | -4.9% | |
SANOFI-AVENTIS-ADR | -4.9% | |
MCKESSON CORP | -4.7% | |
NOVO-NORDISK A/S-SPONS ADR | -4.7% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.6% | |
GLAXOSMITHKLINE PLC-SPON ADR | -4.5% | |
TEVA PHARMACEUTICAL-SP ADR | -4.1% |